[go: up one dir, main page]

RU93020154A - HIV PREVENTION METHOD - Google Patents

HIV PREVENTION METHOD

Info

Publication number
RU93020154A
RU93020154A RU93020154/14A RU93020154A RU93020154A RU 93020154 A RU93020154 A RU 93020154A RU 93020154/14 A RU93020154/14 A RU 93020154/14A RU 93020154 A RU93020154 A RU 93020154A RU 93020154 A RU93020154 A RU 93020154A
Authority
RU
Russia
Prior art keywords
prevention method
hiv prevention
hiv infection
suppress hiv
hiv
Prior art date
Application number
RU93020154/14A
Other languages
Russian (ru)
Other versions
RU2043767C1 (en
Inventor
А.В. Асафов
В.В. Безюлев
И.Г. Аносова
Original Assignee
Научно-производственное предприятие "Фармэк"
Filing date
Publication date
Application filed by Научно-производственное предприятие "Фармэк" filed Critical Научно-производственное предприятие "Фармэк"
Priority claimed from RU93020154A external-priority patent/RU2043767C1/en
Priority to RU93020154A priority Critical patent/RU2043767C1/en
Priority to DE69429812T priority patent/DE69429812T2/en
Priority to ES94913856T priority patent/ES2171450T3/en
Priority to PCT/RU1994/000084 priority patent/WO1994028153A2/en
Priority to SG1996002706A priority patent/SG47539A1/en
Priority to JP7500517A priority patent/JP2772140B2/en
Priority to AU65849/94A priority patent/AU6584994A/en
Priority to AT94913856T priority patent/ATE212848T1/en
Priority to EP94913856A priority patent/EP0712936B1/en
Publication of RU2043767C1 publication Critical patent/RU2043767C1/en
Application granted granted Critical
Publication of RU93020154A publication Critical patent/RU93020154A/en

Links

Claims (1)

Изобретение относится к медицине и может быть использовано для подавления ВИЧ-инфекции, вызывающей СПИД у человека. Сущность изобретения состоит в том, что для подавления ВИЧ-инфекции используют комплексы экзогенной ДНК с поливалентными металлами. Способ обладает высокой противовирусной активностью при низкой токсичности.The invention relates to medicine and can be used to suppress HIV infection that causes AIDS in humans. The essence of the invention lies in the fact that to suppress HIV infection using complexes of exogenous DNA with polyvalent metals. The method has high antiviral activity with low toxicity.
RU93020154A 1993-05-24 1993-05-24 Method for suppressing human virus infection RU2043767C1 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
RU93020154A RU2043767C1 (en) 1993-05-24 1993-05-24 Method for suppressing human virus infection
SG1996002706A SG47539A1 (en) 1993-05-24 1994-04-14 Low molecular deoxribonucleic acid dna of sturgeon milt method for dna extraction and pharmaceutic preparation on the base of dna sturgeon milt
ES94913856T ES2171450T3 (en) 1993-05-24 1994-04-14 LOW-MOLECULAR WEIGHT DNA FROM STURION DATE, PROCEDURE FOR OBTAINING DNA AND PHARMACEUTICAL PREPARATION BASED ON THE SAME.
PCT/RU1994/000084 WO1994028153A2 (en) 1993-05-24 1994-04-14 Low-molecular dna from sturgeon milt, a method of obtaining the dna and a pharmaceutical preparation based on it
DE69429812T DE69429812T2 (en) 1993-05-24 1994-04-14 LOW-MOLECULAR DNA FROM STUNNED MILK, METHOD FOR THE DETERMINATION OF THE DNA AND A PHARMACEUTICAL PREPARATION BASED ON IT
JP7500517A JP2772140B2 (en) 1993-05-24 1994-04-14 Low molecular weight deoxyribonucleic acid (DNA) of sturgeon fish sperm, method for extracting the DNA, and pharmaceutical preparation based on the DNA
AU65849/94A AU6584994A (en) 1993-05-24 1994-04-14 Low-molecular dna from sturgeon milt, a method of obtaining the dna and a pharmaceutical preparation based on it
AT94913856T ATE212848T1 (en) 1993-05-24 1994-04-14 LOW MOLECULAR DNA FROM STURGEON MILK, METHOD FOR OBTAINING DNA AND A PHARMACEUTICAL PREPARATION BASED THEREOF
EP94913856A EP0712936B1 (en) 1993-05-24 1994-04-14 Low-molecular dna from sturgeon milt, a method of obtaining the dna and a pharmaceutical preparation based on it

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU93020154A RU2043767C1 (en) 1993-05-24 1993-05-24 Method for suppressing human virus infection

Publications (2)

Publication Number Publication Date
RU2043767C1 RU2043767C1 (en) 1995-09-20
RU93020154A true RU93020154A (en) 1996-10-10

Family

ID=20140597

Family Applications (1)

Application Number Title Priority Date Filing Date
RU93020154A RU2043767C1 (en) 1993-05-24 1993-05-24 Method for suppressing human virus infection

Country Status (1)

Country Link
RU (1) RU2043767C1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2136286C1 (en) * 1996-01-22 1999-09-10 Каплина Элли Николаевна Antiviral agent to rna- and dna-containing viruses
RU2155591C2 (en) * 1997-01-28 2000-09-10 Задионченко Владимир Семенович Method of treatment of patients with stomach and duodenal intestine ulcer disease
RU2158592C1 (en) * 1999-12-29 2000-11-10 Каплина Элли Николаевна Antiviral immunotropic agent
RU2172632C1 (en) * 2000-12-01 2001-08-27 Каплина Элли Николаевна Method of preparing immunotropic antivaral drug
RU2182828C1 (en) * 2001-02-23 2002-05-27 Поздняков Владимир Николаевич Composition showing anti-hiv and anti-herpes activity
RU2188659C1 (en) * 2001-04-20 2002-09-10 ООО Научно-производственное фармацевтическое предприятие "Полидан" Pharmaceutical composition showing immunotropic effect for human therapy

Similar Documents

Publication Publication Date Title
CA2253490A1 (en) Use of il-12 and ifn-.alpha. for the treatment of infectious diseases
BG102048A (en) Tetrahydrofuran-containing sulphonamides as aspartylprotease inhibitors
BG91270A (en) ANTIVIRAL AND ANTIBACTERIAL AGENT AND METHOD OF ITS USE
FI955315L (en) HIV protease inhibitors useful in the treatment of AIDS
FI911574A7 (en) New HIV proteins and peptides that are useful in the detection, prevention and treatment of AIDS
CA2291994A1 (en) Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents
MD1224B2 (en) Application of nucleoside analogues with 1,3-oxathiolan for treatment of hepatitis B
FI891716A7 (en) HIV protease inhibitors, which are useful in the treatment of AIDS
WO1993017651A3 (en) Antiviral nucleoside analogues, their production and use
RU92016277A (en) MICROBIOCIDES
EP0639076A4 (en) USE OF GUANYLATE CYCLASE INHIBITORS IN THE TREATMENT OF SHOCK CONDITIONS.
EP0296573A3 (en) Novel nucleosides, their preparation and pharmaceutical novel nucleosides, their preparation and pharmaceutical compositions compositions
NO883564L (en) TOPIC ACTIVE PREPARATIONS OF DOUBLE WIRED RNA.
RU93020154A (en) HIV PREVENTION METHOD
ES2081286T3 (en) PYRIMIDINE NUCLEOSIDES ANTIVIRUS AIDS.
DE69403063D1 (en) AGAINST VIRUS-ACTIVE NAPHTOCHINONE COMPOUNDS, COMPOSITIONS AND THEIR USE
AU2880595A (en) Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
EP0323157A3 (en) Antiviral compounds and methods
RU93041779A (en) MEANS FOR THE TREATMENT OF IMMUNE DEFICIENCY STATES
FR2709964B1 (en) Antiviral pharmaceutical compositions proposed in the treatment of AIDS and Herpes.
FI950533L (en) Seco-nucleoside liponucleotides, their preparation and their use as antiviral drugs
ZA888701B (en) Expression of hiv proteins in e.coli and s. cerevisiae
EP0674657A4 (en) GP41 MUTANTS AND THEIR USE AS HIV THERAPEUTICS.
ATE62789T1 (en) AGENT TO COMBAT PHYTOPATHOGENIC MICROBES.
FR2702149B1 (en) Application of lamotrigine in the treatment of neuro-AIDS.